An analysis of the The BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF) cohort in 2329 patients with an LVEF ≤ 40% demonstrated an independent relationship between elevated IL-6 levels and hard CV outcomes [95]. The gene discussed is IL6; the disease is congestive heart failure.